These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 475262)

  • 21. Neutrophil function--part I.
    Lenehan TJ; Greally JF
    Ir Med J; 1975 Dec; 68(23):593-6. PubMed ID: 1052498
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired neutrophil locomotion associated with hyperadhesiveness in a patient with Chédiak-Higashi syndrome.
    Keller HU; Morell A; Schaffner T; Zimmermann A; Schaad U
    Blood Cells; 1984; 10(1):37-43. PubMed ID: 6487813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prolonged remission of infectious symptoms during treatment with ascorbate in a case of Chediak-Higashi syndrome].
    Monciotti C; Colleselli P; Barbato A; Formentin E
    Pediatr Med Chir; 1983; 5(5):433-6. PubMed ID: 6544429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous manifestations of immunogenetic deficiency disorders.
    Dwyer JM
    Birth Defects Orig Artic Ser; 1981; 17(2):93-115. PubMed ID: 7199952
    [No Abstract]   [Full Text] [Related]  

  • 25. Chediak-Higashi syndrome--a case report.
    Kapoor A; Munjal S; Arya R
    Indian J Pathol Microbiol; 2000 Jul; 43(3):373-5. PubMed ID: 11218692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: clinical and laboratory approach to the management of neutrophil dysfunction.
    Wolach B; Baehner RL; Boxer LA
    Isr J Med Sci; 1982 Sep; 18(9):897-916. PubMed ID: 6754659
    [No Abstract]   [Full Text] [Related]  

  • 27. Complement activation products and monocyte migratory function in trauma.
    Antrum RM; Solomkin JS
    Curr Surg; 1985; 42(4):301-3. PubMed ID: 3875452
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chédiak-Higashi disease (report on a new case) (author's transl)].
    Deprez P; Laurent R; Griscelli C; Buriot D; Agache P
    Ann Dermatol Venereol; 1978 Oct; 105(10):841-9. PubMed ID: 747294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Participation of polymorphonuclear leukocytes in basic defensive mechanisms].
    Chabior M; Baranowska B; Kozłowski M
    Pediatr Pol; 1981 Mar; 56(3):327-33. PubMed ID: 7019835
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotaxis.
    Becker EL
    J Allergy Clin Immunol; 1980 Aug; 66(2):97-105. PubMed ID: 6249863
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotaxis of polymorphonuclear leukocytes in response to surface-bound complement-derived chemoattractants generated in situ.
    Dahlgren C; Hed J; Stendahl O
    Inflammation; 1984 Jun; 8(2):201-8. PubMed ID: 6378792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5 fragments: are they important in polymorphonuclear leucocyte diapedesis?
    Russo M; Arruda AM; Jancar S
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):361-9. PubMed ID: 3738213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of polymorphonuclear leukocyte function. II.
    Boxer GJ; Curnutte JT; Boxer LA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):129-34, 136-8. PubMed ID: 3932416
    [No Abstract]   [Full Text] [Related]  

  • 34. The Chédiak-Higashi syndrome. Evidence that defective leukotaxis is primarily due to an impediment by giant granules.
    Clawson CC; White JG; Repine JE
    Am J Pathol; 1978 Sep; 92(3):745-53. PubMed ID: 686156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.
    Kesarwala HH; Prasad RV; Szep R; Oldman E; Lane S; Papageorgiou PS
    Clin Exp Immunol; 1979 Jun; 36(3):465-72. PubMed ID: 487648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis.
    Hill HR; Estensen RD; Hogan NA; Quie PG
    J Lab Clin Med; 1976 Nov; 88(5):796-806. PubMed ID: 978042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with disorders of phagocytic cell function.
    Quie PG; Hetherington SV
    Pediatr Infect Dis; 1984; 3(3):272-80. PubMed ID: 6377259
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical observations of defective monocyte chemotaxis].
    Yamazaki T; Yamazaki M; Yasui K; Komiyama A; Akabane T
    Rinsho Ketsueki; 1985 Sep; 26(9):1463-6. PubMed ID: 4087395
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor.
    Colgan SP; Gasper PW; Thrall MA; Boone TC; Blancquaert AM; Bruyninckx WJ
    Exp Hematol; 1992 Nov; 20(10):1229-34. PubMed ID: 1385198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotaxis.
    Kretschmer RR; Collado ML
    Infection; 1980; 8 Suppl 3():S 299-302. PubMed ID: 6997207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.